633 results
When mitral disease is not the only problem on mitral TEER patients
22 May 2025 – From EuroPCR 2025
Explore the multifaceted challenges in patients undergoing mitral TEER when additional mitral and tricuspid pathologies coexist. This session reviews data from the EXPANDed studies on tricuspid regurgitation post-mitral TEER, one-year outcomes based on cardiac damage extent, pulmonary hypertension dynamics, and the long-term mortality causes in this...
Mitral TEER in challenging scenarios - Part 1
22 May 2025 – From EuroPCR 2025
Confront challenging clinical scenarios in mitral transcatheter edge-to-edge repair (TEER) with this session highlighting unique case experiences. Topics include innovative approaches to transcatheter mitral valve repair, urgent management of critical complications such as severe mitral regurgitation causing respiratory distress, and complex interventions in resource-limited settings such...
TEER for challenging anatomy: from myth to reality
21 May 2025 – From EuroPCR 2025
Explore advanced TEER techniques for challenging anatomies. This session covers indications, periprocedural steps, state-of-the-art procedural methods, and management of failed surgical tricuspid annuloplasty, with case discussions highlighting practical learnings for complex mitral and tricuspid interventions.
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.
From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions
21 May 2025 – From EuroPCR 2025
Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...
Innovations in TMVR and Intrepid trial updates
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...
Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation
21 May 2025 – From EuroPCR 2025
Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....
Enhancing clipping solutions for durable long-term patient outcomes
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...
Right heart catheterisation and CT scan for the assessment of A-V valve treated percutaneously
21 May 2025 – From EuroPCR 2025
This session evaluates right heart catheterisation and cardiac CT imaging in the assessment of percutaneously treated atrioventricular valves. Explore clinical outcomes, invasive physiology characterization, annular remodeling, and pulmonary hypertension impact on mitral and tricuspid valve interventions.
Mitral TEER in challenging scenarios - Part 3
21 May 2025 – From EuroPCR 2025
This session focuses on challenging mitral TEER cases, including papillary muscle rupture post-myocardial infarction, advanced heart failure treatment, emerging therapies for mitral regurgitation, and novel percutaneous repair techniques.
